{"entity":{"id":"paper-ngcamphalala-economic-burden-cervical-cancer-eswatini-plosone-2021","kind":"paper","name":"The economic burden of cervical cancer in Eswatini, 2018","aka":[],"tldr":"Cervical cancer cost Eswatini's society an estimated 19 million US dollars in 2018, most of it the direct cost of treating invasive cancer at late stages.","summary":"Published as \"The economic burden of cervical cancer in Eswatini: Societal perspective\". A cost-of-illness study using national clinical and registry data for 2018, counting direct medical costs, patients' travel costs, and productivity lost to illness and early death.","asOf":"2026-11-16","links":[{"label":"PLoS One 2021","url":"https://doi.org/10.1371/journal.pone.0250113"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/33857233/"}],"tags":[],"related":["paper-ngcamphalala-economic-burden-prostate-cancer-eswatini-bmchsr-2022","paper-maseko-hpv-vaccine-introduction-eswatini-apjcp-2025"],"cancers":["cervical"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["eswatini-ministry-of-health"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"journal":"PLoS One","year":2021,"doi":"10.1371/journal.pone.0250113","pmid":"33857233","authors":"Ngcamphalala C, Östensson E, Ginindza TG.","paperType":"observational","findings":["Total annual cost was $19 million (range $14 million to $24 million).","Direct costs were 72% ($13.7 million); treating pre-cancer was 0.7% of them ($94,161).","Treatment of stage III and stage IV disease cost $1.7 million and $8.7 million.","Indirect costs were 27% ($5.3 million), 67% of that from early death ($3.5 million)."],"whatItMeans":"More than half of the total, $10.4 million of $19 million, is the cost of treating stage III and stage IV disease, and less than 1% of direct costs goes on treating pre-cancer. The authors conclude that HPV vaccination and screening should be prioritised.","caveats":["A model built from 2018 data, before the oncology unit at Manzini and before HPV vaccination.","The abstract does not say how much of the cost was treatment abroad."]},"route":"/key-papers/paper-ngcamphalala-economic-burden-cervical-cancer-eswatini-plosone-2021/","neighbours":{"paper":[{"id":"paper-maseko-hpv-vaccine-introduction-eswatini-apjcp-2025","kind":"paper","name":"Introduction of the HPV vaccine in Eswatini: the June 2023 school campaign","route":"/key-papers/paper-maseko-hpv-vaccine-introduction-eswatini-apjcp-2025/"},{"id":"paper-ngcamphalala-economic-burden-prostate-cancer-eswatini-bmchsr-2022","kind":"paper","name":"The economic burden of prostate cancer in Eswatini, 2018","route":"/key-papers/paper-ngcamphalala-economic-burden-prostate-cancer-eswatini-bmchsr-2022/"}],"cancer":[{"id":"cervical","kind":"cancer","name":"Cervical cancer","route":"/cancers/cervical/"}],"institution":[{"id":"manzini-oncology-unit","kind":"institution","name":"Manzini Oncology Unit","route":"/institutions/manzini-oncology-unit/"},{"id":"eswatini-ministry-of-health","kind":"institution","name":"Ministry of Health, Eswatini","route":"/institutions/eswatini-ministry-of-health/"}]}}